CORONA Remedies reports 7 insider code violations by employees
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
CORONA Remedies informed exchanges of 7 violations of the insider trading code by designated persons and their relatives. On December 15, 2025, all 7 traded shares during a trading window closure period, described as inadvertent. The company issued written warnings, levied penalties of about Rs 10,000 each (one of Rs 35,000), and required profit disgorgement from two of them. Total amounts have been paid to SEBI's Investor Protection Fund.
Minor compliance lapse by 7 employees, already addressed with warnings and small penalties paid to SEBI. Negligible impact on shareholders.